Kyoto University Traces Blood Cell Evolution
Analysis based on 8 articles · First reported May 25, 2026 · Last updated May 28, 2026
This breakthrough in understanding blood cell evolution could significantly impact the biotechnology and pharmaceutical industries by opening new avenues for research into diseases like Cancer. Companies involved in drug discovery and diagnostics related to immunology and hematology may see increased investment and development opportunities.
Researchers at Kyoto University, led by Hiroshi Kawamoto and first author Yosuke Nagahata, have unveiled the 700-million-year evolutionary history of blood cells, tracing their origins back to single-celled ancestors. They developed a new analytical method to compare gene expression profiles across species, revealing that early blood cells were macrophage-like and that the FOS gene is a key ancient marker. The study reconstructed the family tree of blood cells, showing how mast cells, T cells, B cells, and red blood cells branched off over time. This discovery not only deepens our understanding of hematology and immunology but also offers potential insights into the evolutionary origins of diseases such as Cancer, paving the way for new treatments.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard